OpenExamsFREE PRACTICE — ANY EXAM

New York Pharmacist — Requirements & Free Practice

US-NY · License preparation

827 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist

License required to use the title "pharmacist" in New York State.

Licensing authority: New York State Education Department · Application information

Licensure by endorsement of a pharmacist license issued by another jurisdiction
Multistate Pharmacy Jurisprudence Examination
Application
Submit the Application for Licensure (Form 1) with the $339 fee and apply for licensure transfer through NABP's Electronic Licensure Transfer Program (e-LTP); foreign graduates also submit Form 2.
License Elsewhere
Hold a pharmacist license issued by another jurisdiction and meet the requirements of Education Law §6506(6) (application, education, experience, examination satisfactory to the board, age 21, good moral character, prior professional conduct) as applied by 8 NYCRR §59.6, except the two-year post-licensure experience requirement (8 NYCRR §63.5(a)).
Military Spouse Expedited Review
An applicant who is the spouse of an active duty member of the armed forces transferred to New York receives expedited review; the department shall issue a license if the applicant holds a license in good standing in another state whose requirements are, in the department's opinion, substantially equivalent (Education Law §6501(2)(a)).
No Unsuccessful New York Exam Attempt
Has not attempted unsuccessfully a licensing examination used by New York, unless later passing a comparable licensing examination (8 NYCRR §59.6(c)).
Part IIISpecial Provisions
Applicants who previously applied but did not obtain licensure because of the Part III examination submit the Special Provisions Form (Form 1A) (Board's License Requirements page; 8 NYCRR §63.3(c)).
Prior Licensing Examination
Education Law §6506(6) requires having passed an examination satisfactory to the board; the Board's page directs California licensees who have not passed the NAPLEX, Canadian licensees and graduates of foreign pharmacy programs to contact the State Board of Pharmacy regarding endorsement.
Regents Waiver
The Board of Regents may waive education, experience and examination requirements when satisfied that the requirements of Article 137 have been substantially met (Education Law §6506(5)).
Licensure by examination: graduate of a registered or ACPE accredited pharmacy program
Age
At least 21 years of age (Education Law §6805).
Application
File the Application for Licensure (Form 1) with the licensure and first registration fee ($339 per the Board's License Requirements page).
Citizenship Or Immigration Status
Education Law §6805 lists U.S. citizenship or lawful permanent residence, but 8 NYCRR §59.4 provides that no otherwise qualified applicant shall be denied a license by reason of citizenship or immigration status unless otherwise ineligible under 8 USC §1621 or other federal law.
Discontinued Part III
The Prescription Compounding and Pharmacy Practice (Part III) examination is no longer required effective January 1, 2022; applicants who previously applied but were not licensed because of Part III may submit the Special Provisions Form (Form 1A) for review against the revised requirements (8 NYCRR §63.3(c)).
Education
Completed a pharmacy program leading to a bachelor's degree or higher that is registered by the department or accredited by an acceptable accrediting agency (ACPE) (8 NYCRR §63.1(b)(1)); the Board's page also treats CCAPP-accredited programs completed between 1993 and 2004 on the same basis and directs CCAPP graduates before 1993 to the non-accredited documentation.
Examination Order And Timing
Both parts of the licensing examination series (NAPLEX and MPJE) must be passed within 5 years; credit for passing scores is retained for no more than five years (8 NYCRR §63.3(b)). NAPLEX admission requires an approved Form 1 and education documentation; MPJE admission additionally requires approved internship experience unless a PharmD graduate.
Experience
Doctor of Pharmacy graduates of registered or accredited programs are considered to have completed the internship (8 NYCRR §63.2(c)); bachelor's-degree graduates need at least six months (1,040 hours) of full-time internship under a limited (intern) permit before admission to the MPJE (8 NYCRR §63.2(a)).
Good Moral Character
Good moral character as determined by the department (Education Law §6805).
Regents Waiver
The Board of Regents may waive education, experience and examination requirements when satisfied that the requirements of Article 137 have been substantially met (Education Law §6506(5)).
Licensure by examination: graduate of a non registered or non accredited (including foreign) pharmacy program
Age
At least 21 years of age (Education Law §6805).
Application
File the Application for Licensure (Form 1) with the licensure and first registration fee ($339 per the Board's License Requirements page).
Citizenship Or Immigration Status
Education Law §6805 lists U.S. citizenship or lawful permanent residence, but 8 NYCRR §59.4 provides that no otherwise qualified applicant shall be denied a license by reason of citizenship or immigration status unless otherwise ineligible under 8 USC §1621 or other federal law.
Education
Completed a pharmacy program at the bachelor's level or equivalent recognized by the civil authorities of its jurisdiction, determined by the department to be equivalent to a registered program (preprofessional and professional study requirements on the Board's page) (8 NYCRR §63.1(b)(3)).
English Proficiency
Applicants educated where English is not the principal language must demonstrate English proficiency by passing an English proficiency examination acceptable to the department or a licensing examination given in English (8 NYCRR §59.3); the Board's page names the TOEFL iBT.
Examination Timing
Credit for passing scores on each required examination is retained for no more than five years (8 NYCRR §63.3(b)).
Experience
Not less than 12 months (2,080 hours) of full-time internship after passing the initial examination(s) (8 NYCRR §63.2(b)).
Fpgec Certification
Foreign Pharmacy Graduate Examination Committee (FPGEC) certification by NABP or an equivalent certification acceptable to the department (8 NYCRR §63.1(b)(3)); the Board's page lists passing the TOEFL iBT and the FPGEE to obtain FPGEC certification.
Good Moral Character
Good moral character as determined by the department (Education Law §6805).
Regents Waiver
The Board of Regents may waive education, experience and examination requirements when satisfied that the requirements of Article 137 have been substantially met (Education Law §6506(5)).
Sequence
The Board's page lists the steps in order: FPGEC certification, Form 1 and fee, Form 2, NAPLEX, limited (intern) permit (Form 5), 12 months (2,080 hours) of internship, Form 4, then MPJE; the internship may begin only after passing the initial examination(s) (8 NYCRR §63.2(b)).
Triennial registration renewal (including resumption of practice after a lapse of registration)
No examination is required for this applicant pathway.
Application
Submit the registration application on the department's form with the registration fee (Education Law §6502(3)).
Continuing Education
Complete at least 45 hours of acceptable formal continuing education per triennial registration period, no more than 22 hours of self-study, including required subject hours (Education Law §6827; 8 NYCRR §63.7(c)); a conditional registration may be issued at the department's discretion to a licensee who agrees to make up deficiencies (Education Law §6827(3)).
Lapse In Practice
A licensee returning to practice after a lapse of registration must meet the continuing education requirements for resumption of practice (Education Law §6827(1)(c); 8 NYCRR §63.7(c)(2)).

Official no-examination sources

Effective from 2022-01-01.

limited (intern) permit

Permit for pharmacy internship under the direct supervision of a licensed, currently registered pharmacist; valid for five years and renewable once at the department’s discretion for an additional two years.

Licensing authority: new york state education department · Application information

Limited (intern) permit: graduate of a non registered or non accredited (including foreign) pharmacy program
Application
Submit Online Form 1 with the $339 fee and have the school send Form 2 and an official transcript directly to the department before applying for the permit.
Fpgec Certification
FPGEC certification by NABP, which the Board's page lists as requiring the TOEFL iBT and the FPGEE.
Immunization Privileges
Graduates of non-ACPE accredited programs are not eligible for immunization privileges under a limited (intern) permit (Board's License Requirements page).
Purpose
Issued to complete the 12-month internship required of non-registered or non-accredited program graduates (8 NYCRR §63.4(a)(2); §63.2(b)).
Limited (intern) permit: student or graduate of a registered or accredited pharmacy program
No examination is required for this applicant pathway.
Application
Submit Online Form 5 with the $70 non-refundable fee; the school submits Form PH20-Intern (New York programs) or Form 2InternB (non-resident ACPE programs).
Eligibility
A student in the last two years of a registered program who has completed the first year of professional study, or a graduate of a program meeting the commissioner's standards who is meeting the experience requirement or whose initial licensure application is pending (Education Law §6806(1); 8 NYCRR §63.4(a)(1)).
Immunization Certification
An intern may administer immunizations only with a certificate of administration after completing approved training within three years (Education Law §6806; 8 NYCRR §63.4(d)).

Official no-examination sources

Effective from 2022-01-01.

Limited (intern) permit renewal
No examination is required for this applicant pathway.
Renewal
May be renewed once, at the department's discretion, for up to two years from the expiration of the initial five-year permit (Education Law §6806(4)); submit a new Online Form 5 with the $70 fee; immunization privileges are subject to recertification at renewal.

Official no-examination sources

Effective from 2022-01-01.

Foreign Pharmacy Graduate Equivalency Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
200 questions
Time limit
4.5 hours examination time; 5.5 hours total seat time
Passing score
Scaled score of 75
Examination outline
  • Foundational Biomedical Sciences (12%)
    • Anatomy and physiology
    • Biochemistry
    • Medical microbiology
    • Immunology
    • Pathophysiological bases of diseases
  • Pharmaceutical Sciences (31%)
    • Pharmaceutical calculations (eg, dose adjustments, delivery, ionization, ionic strength, isotonicity, ratio/percentage strength, osmolarity)
    • Medicinal chemistry
    • Medicinal chemistry: Physicochemical properties of drugs in relation to drug absorption, distribution, metabolism, and excretion (ADME)
    • Medicinal chemistry: Pathways of drug metabolism
    • Medicinal chemistry: Chemical bases for drug action, including bioorganic chemistry, structure-activity relationships, and fundamental pharmacophores related to drug-receptor interactions
    • Medicinal chemistry: Applicability to making drug therapy decisions
    • Pharmacology and toxicology
    • Pharmacology and toxicology: Pharmacodynamics, including drug-receptor interactions, agonists, antagonists, inverse agonists, and dose-response curves
    • Pharmacology and toxicology: Mechanisms of action of drugs, including biologics
    • Pharmacology and toxicology: Adverse effects and side effects of drugs
    • Pharmacology and toxicology: Mechanisms of drug interactions, including drug-drug, drug-disease, drug-food, drug-allergy, and drug-laboratory interactions
    • Pharmacology and toxicology: Mechanisms of acute and chronic toxic effects of xenobiotics, including drug and chemical overdose or exposure and antidotes
    • Pharmaceutics and biopharmaceutics
    • Pharmaceutics and biopharmaceutics: Dosage form development and drug delivery systems such as immediate release, sustained release, and controlled release
    • Pharmaceutics and biopharmaceutics: Disintegration and dissolution of solid oral dosage forms
    • Pharmaceutics and biopharmaceutics: Physicochemical properties of drugs, excipients, solutions, and dosage forms
    • Pharmaceutics and biopharmaceutics: Physical stability, chemical stability, and shelf-lives, including zero-, first-, second-, and pseudo-order reactions
    • Pharmaceutics and biopharmaceutics: Interactions between drug formulation and biological effects
    • Pharmaceutics and biopharmaceutics: Drug product manufacturing, including methods, processing, and quality assurance
    • Pharmacokinetics
    • Pharmacokinetics: Determining rates of absorption, distribution, metabolism, and excretion (ADME) of drugs
    • Pharmacokinetics: Factors affecting rates of ADME, including age, sex, genetics, diet, disease, and drug interactions
    • Pharmacokinetics: Biological half-lives of drugs and related dosing
    • Pharmacokinetics: Compartment models (one-, two-, and non-)
    • Pharmacokinetics: Linear and nonlinear pharmacokinetics
    • Pharmacokinetics: Principles of bioavailability, bioequivalence, and biosimilars
    • Pharmacogenomics (eg, population-based genetic influences on drug metabolism and efficacy, genetic testing, tumor genotyping, pharmacogenetic screening)
    • Extemporaneous compounding (eg, United States Pharmacopeia (USP) standards including Chapters <795>, <797>, and <800>; dosage form preparation calculations; techniques used to prepare and dispense sterile and nonsterile preparations)
  • Social, Behavioral, and Administrative Sciences (20%)
    • Pharmacy law and ethics
    • Pharmacy law and ethics: Laws and regulations governing pharmacy
    • Pharmacy law and ethics: Regulatory, oversight, and professional organizations
    • Pharmacy law and ethics: Principles and application of biomedical ethics
    • Health care systems
    • Health care systems: Organization, regulation, and financing of health care delivery in the United States
    • Health care systems: Factors that influence delivery and use of health care (eg, social, political, economic, and technological)
    • Pharmacoeconomics (eg, analysis, interpretation, application, humanistic outcomes)
    • Population-based care, pharmacoepidemiology, and public health
    • Population-based care, pharmacoepidemiology, and public health: Data sources and analytic tools
    • Population-based care, pharmacoepidemiology, and public health: Application of epidemiological study design
    • Population-based care, pharmacoepidemiology, and public health: Health promotion, disease prevention, and infection control
    • Population-based care, pharmacoepidemiology, and public health: Continuous quality improvement
    • Population-based care, pharmacoepidemiology, and public health: Social determinants and drivers of health
    • Practice management
    • Practice management: Financial management and budgeting
    • Practice management: Personnel management
    • Practice management: Business and strategic planning
    • Practice management: Risk management
    • Practice management: Procurement and inventory control
    • Professional communication
    • Professional communication: Verbal, nonverbal, written, and technology-based communication with patients, caregivers, providers, and stakeholders
    • Professional communication: Health literacy
    • Biostatistics and research methods (eg, study design, statistical tests, data collection instruments, research ethics)
    • Social and behavioral aspects of practice
    • Social and behavioral aspects of practice: Patient behavior including health-, illness-, and sick-role
    • Social and behavioral aspects of practice: Principles of behavior modification
    • Social and behavioral aspects of practice: Patient adherence
    • Social and behavioral aspects of practice: Cultural awareness
  • Pharmacy Practice and Clinical Sciences (37%)
    • Clinical pathophysiology as it applies to treatment of disease processes
    • Data collection (eg, patient history, physical assessments, laboratory values, point-of-care testing)
    • Data assessment (eg, clinical calculations, interpretation of data, diagnosing)
    • Patient-care decision making, therapy recommendations, and education (eg, plan, implement, monitor, follow-up)
    • Patient safety (eg, drug interactions, toxicity, drug-induced disease, drug use disorders)
    • Disease prevention (eg, screenings, immunization, non-pharmacological therapies, lifestyle modifications)
    • Personalized medicine (eg, pharmacokinetics, pharmacogenetics)
    • Evidence-based practice
    • Evidence-based practice: Practice guidelines
    • Evidence-based practice: Drug information and evaluation
    • Evidence-based practice: Information source reliability
    • Evidence-based practice: Clinical trial evaluation
    • Self-care, including using natural products
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Multistate Pharmacy Jurisprudence Examination

Provider
National Association of Boards of Pharmacy (NABP); scheduled with Pearson
Format
Computer-based adaptive exam of selected-response questions; New York State-specific version
Exam questions
120
Time limit
2.5 hours
Passing score
Reported as pass or fail; the passing score is determined by the New York State Education Department (8 NYCRR 63.3(a))
Examination outline
  • Area 1 — Licensure/Personnel (22%)
    • Responsibilities of the pharmacist and non-pharmacist personnel: qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists; qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for non-pharmacist personnel
    • Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel: qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications; classifications and processes of disciplinary actions; reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Area 2 — Pharmacist Practice (33%)
    • Requirements for issuing prescriptions/drug orders: requirements for drug uses, limitations, or restrictions; scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs; requirements for issuing non-controlled prescriptions/drug orders; requirements for issuing controlled prescriptions/drug orders; authority limitations of practitioners' ability to authorize refills
    • Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients' therapy
    • Requirements regarding counseling: counseling or offering to counsel; documenting counseling or documenting offering to counsel
    • Returning or reusing drugs
    • Regulations and agencies regarding pharmacy practice: requirements for promoting quality and safety of public health; protecting patient and health record confidentiality
  • Area 3 — Dispensing Requirements (24%)
    • Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • Transferring prescription/drug order information between pharmacies by authorized personnel
    • Prospective drug utilization reviews: requirements for reporting to PMP and accessing PMP data
    • Exceptions to dispensing or refilling prescriptions/drug orders
    • Labeling of dispensed drugs
    • Packaging of dispensed drugs
    • Drug product conditions prohibiting dispensing
    • Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs: dispensing or administration; labeling of non-prescription drugs and devices; packaging and repackaging of non-prescription drugs and behind-the-counter products; dispensing-restricted, non-prescription drugs
  • Area 4 — Pharmacy Operations (21%)
    • Ordering, acquisition, and distribution of drugs, including maintenance and content of such records: ordering and acquisition, including the maintenance and content of such records; distribution, including the maintenance and content of such records
    • Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting: non-dispensing requirements for operations of pharmacies or practice settings; possession, storage, and handling of non-hazardous drugs; training, possession, handling, storage, and disposal of hazardous drugs; allowing non-pharmacist personnel access to drugs; requirements for conducting controlled substance inventories
    • Delivery of drugs
    • Conditions for permitted or mandated product selection
    • Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • Centralized prescription processing or central-fill pharmacy dispensing
    • Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity: requirements for registration, license, certification, or permitting of a practice setting; requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting; requirements for an inspection of a licensed, registered, certified, or permitted practice setting; classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
Examination sources